These findings provide mechanistic insights into NPC metastasis and define therapeutic targets in the FGF-2/FGFR1/pericyte/CXCL14/TAMs axis for treating metastasis of NPC or FGF-2–expressing malignancies. Here, FGFR1 is linked to nasopharyngeal carcinoma.